Share on StockTwits

Avacta Group Plc (LON:AVCT)‘s stock had its “buy” rating restated by analysts at Panmure Gordon in a research report issued to clients and investors on Friday, Analyst Ratings reports. They currently have a GBX 1.75 ($0.03) price objective on the stock. Panmure Gordon’s target price would indicate a potential upside of 54.32% from the stock’s previous close.

Separately, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Avacta Group Plc in a research note to investors on Friday, January 24th. They now have a GBX 1.70 ($0.03) price target on the stock.

Avacta Group Plc (LON:AVCT) traded up 0.80% on Friday, hitting GBX 1.134. The stock had a trading volume of 15,764,040 shares. Avacta Group Plc has a 1-year low of GBX 0.44 and a 1-year high of GBX 1.134. The stock’s 50-day moving average is GBX 1.09 and its 200-day moving average is GBX 0.93.

Avacta Group plc is engaged in healthcare equipment and instrumentation business, provides technologies and services to the life sciences/healthcare sector through two operating divisions: Avacta Analytical and Avacta Animal Health.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.